Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable insulin-like growth factor binding activity. Acts upstream of or within extracellular matrix organization. Located in interstitial matrix. Is expressed in several structures, including bone; cap mesenchyme; jaw; nose; and testis. Orthologous to human KAZALD1 (Kazal type serine peptidase inhibitor domain 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.